| regulation of phosphate metabolic process (GO:0019220) | 2.35 | 2 | FGFR1, FGFR2 |
| regulation of primary metabolic process (GO:0080090) | 1.08 | 2 | FGFR1, FGFR2 |
| regulation of metabolic process (GO:0019222) | 1.02 | 2 | FGFR1, FGFR2 |
| positive regulation of lipase activity (GO:0060193) | 5.54 | 2 | FGFR1, FGFR2 |
| positive regulation of response to stimulus (GO:0048584) | 2.18 | 2 | FGFR1, FGFR2 |
| regulation of response to stimulus (GO:0048583) | 1.54 | 2 | FGFR1, FGFR2 |
| somatic stem cell division (GO:0048103) | 6.78 | 2 | FGFR1, FGFR2 |
| signal transduction (GO:0007165) | 1.28 | 2 | FGFR1, FGFR2 |
| cell surface receptor signaling pathway (GO:0007166) | 2.09 | 2 | FGFR1, FGFR2 |
| enzyme linked receptor protein signaling pathway (GO:0007167) | 3.24 | 2 | FGFR1, FGFR2 |
| transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169) | 3.54 | 2 | FGFR1, FGFR2 |
| cellular component organization or biogenesis (GO:0071840) | 1.22 | 2 | FGFR1, FGFR2 |
| morphogenesis of an epithelium (GO:0002009) | 4.08 | 2 | FGFR1, FGFR2 |
| single-organism metabolic process (GO:0044710) | 1.63 | 2 | FGFR1, FGFR2 |
| single-organism biosynthetic process (GO:0044711) | 2.8 | 2 | FGFR1, FGFR2 |
| negative regulation of macromolecule metabolic process (GO:0010605) | 2.01 | 2 | FGFR1, FGFR2 |
| positive regulation of cell cycle (GO:0045787) | 3.94 | 2 | FGFR1, FGFR2 |
| regulation of mesenchymal cell proliferation (GO:0010464) | 6.17 | 2 | FGFR1, FGFR2 |
| regulation of signal transduction (GO:0009966) | 1.84 | 2 | FGFR1, FGFR2 |
| cellular developmental process (GO:0048869) | 1.82 | 2 | FGFR1, FGFR2 |
| MAPK cascade (GO:0000165) | 3.91 | 2 | FGFR1, FGFR2 |
| peptidyl-amino acid modification (GO:0018193) | 2.98 | 2 | FGFR1, FGFR2 |
| regulation of osteoblast differentiation (GO:0045667) | 4.99 | 2 | FGFR1, FGFR2 |
| animal organ development (GO:0048513) | 2.53 | 2 | FGFR1, FGFR2 |
| positive regulation of molecular function (GO:0044093) | 2.23 | 2 | FGFR1, FGFR2 |
| phosphorylation (GO:0016310) | 2.63 | 2 | FGFR1, FGFR2 |
| positive regulation of biological process (GO:0048518) | 1.2 | 2 | FGFR1, FGFR2 |
| phosphatidylinositol biosynthetic process (GO:0006661) | 4.94 | 2 | FGFR1, FGFR2 |
| regulation of cell proliferation (GO:0042127) | 2.41 | 2 | FGFR1, FGFR2 |
| regulation of striated muscle tissue development (GO:0016202) | 5.09 | 2 | FGFR1, FGFR2 |
| regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 2 | FGFR1, FGFR2 |
| cell development (GO:0048468) | 3.28 | 2 | FGFR1, FGFR2 |
| regulation of phospholipase activity (GO:0010517) | 5.57 | 2 | FGFR1, FGFR2 |
| phosphatidylinositol metabolic process (GO:0046488) | 4.46 | 2 | FGFR1, FGFR2 |
| regulation of RNA biosynthetic process (GO:2001141) | 1.55 | 2 | FGFR1, FGFR2 |
| glycerolipid metabolic process (GO:0046486) | 3.91 | 2 | FGFR1, FGFR2 |
| regulation of phosphorylation (GO:0042325) | 2.5 | 2 | FGFR1, FGFR2 |
| single organism signaling (GO:0044700) | 3.25 | 2 | FGFR1, FGFR2 |
| positive regulation of phosphorylation (GO:0042327) | 2.9 | 2 | FGFR1, FGFR2 |
| single-multicellular organism process (GO:0044707) | 1.78 | 2 | FGFR1, FGFR2 |
| positive regulation of cardiac muscle cell proliferation (GO:0060045) | 6.78 | 2 | FGFR1, FGFR2 |
| protein metabolic process (GO:0019538) | 1.45 | 2 | FGFR1, FGFR2 |
| forebrain neuroblast division (GO:0021873) | 7.78 | 2 | FGFR1, FGFR2 |
| ventricular zone neuroblast division (GO:0021847) | 8.63 | 2 | FGFR1, FGFR2 |
| cell communication (GO:0007154) | 3.04 | 2 | FGFR1, FGFR2 |
| organophosphate metabolic process (GO:0019637) | 3.04 | 2 | FGFR1, FGFR2 |
| positive regulation of cardiac muscle tissue growth (GO:0055023) | 6.59 | 2 | FGFR1, FGFR2 |
| skeletal system morphogenesis (GO:0048705) | 4.98 | 2 | FGFR1, FGFR2 |
| negative regulation of metabolic process (GO:0009892) | 1.93 | 2 | FGFR1, FGFR2 |
| positive regulation of metabolic process (GO:0009893) | 1.74 | 2 | FGFR1, FGFR2 |
| negative regulation of biosynthetic process (GO:0009890) | 2.47 | 2 | FGFR1, FGFR2 |
| regulation of anatomical structure morphogenesis (GO:0022603) | 2.79 | 2 | FGFR1, FGFR2 |
| regulation of signaling (GO:0023051) | 1.72 | 2 | FGFR1, FGFR2 |
| neuroblast division (GO:0055057) | 7.53 | 2 | FGFR1, FGFR2 |
| positive regulation of muscle tissue development (GO:1901863) | 5.67 | 2 | FGFR1, FGFR2 |
| metabolic process (GO:0008152) | 0.58 | 2 | FGFR1, FGFR2 |
| negative regulation of gene expression (GO:0010629) | 2.48 | 2 | FGFR1, FGFR2 |
| morphogenesis of a branching structure (GO:0001763) | 4.71 | 2 | FGFR1, FGFR2 |
| negative regulation of RNA biosynthetic process (GO:1902679) | 2.7 | 2 | FGFR1, FGFR2 |
| (GO:1905330) | 4.56 | 2 | FGFR1, FGFR2 |
| intracellular signal transduction (GO:0035556) | 2.39 | 2 | FGFR1, FGFR2 |
| regulation of biological process (GO:0050789) | 0.45 | 2 | FGFR1, FGFR2 |
| cellular protein metabolic process (GO:0044267) | 1.63 | 2 | FGFR1, FGFR2 |
| regulation of cell communication (GO:0010646) | 1.73 | 2 | FGFR1, FGFR2 |
| positive regulation of GTPase activity (GO:0043547) | 3.28 | 2 | FGFR1, FGFR2 |
| positive regulation of hydrolase activity (GO:0051345) | 2.91 | 2 | FGFR1, FGFR2 |
| regulation of GTPase activity (GO:0043087) | 3.21 | 2 | FGFR1, FGFR2 |
| glycerophospholipid metabolic process (GO:0006650) | 4.13 | 2 | FGFR1, FGFR2 |
| cellular component organization (GO:0016043) | 1.24 | 2 | FGFR1, FGFR2 |
| positive regulation of striated muscle tissue development (GO:0045844) | 5.69 | 2 | FGFR1, FGFR2 |
| regulation of organ growth (GO:0046620) | 5.41 | 2 | FGFR1, FGFR2 |
| biological regulation (GO:0065007) | 0.39 | 2 | FGFR1, FGFR2 |
| signal transduction by protein phosphorylation (GO:0023014) | 3.79 | 2 | FGFR1, FGFR2 |
| phosphatidylinositol phosphorylation (GO:0046854) | 5.19 | 2 | FGFR1, FGFR2 |
| regulation of molecular function (GO:0065009) | 1.78 | 2 | FGFR1, FGFR2 |
| regulation of MAPK cascade (GO:0043408) | 3.22 | 2 | FGFR1, FGFR2 |
| anatomical structure formation involved in morphogenesis (GO:0048646) | 3.01 | 2 | FGFR1, FGFR2 |
| regulation of muscle tissue development (GO:1901861) | 5.07 | 2 | FGFR1, FGFR2 |
| organ morphogenesis (GO:0009887) | 3.55 | 2 | FGFR1, FGFR2 |
| positive regulation of cardiac muscle tissue development (GO:0055025) | 6.33 | 2 | FGFR1, FGFR2 |
| lipid metabolic process (GO:0006629) | 2.68 | 2 | FGFR1, FGFR2 |
| regulation of developmental process (GO:0050793) | 2.1 | 2 | FGFR1, FGFR2 |
| regulation of cardiac muscle tissue development (GO:0055024) | 5.86 | 2 | FGFR1, FGFR2 |
| regulation of catalytic activity (GO:0050790) | 1.97 | 2 | FGFR1, FGFR2 |
| regulation of biosynthetic process (GO:0009889) | 1.37 | 2 | FGFR1, FGFR2 |
| tissue development (GO:0009888) | 3.27 | 2 | FGFR1, FGFR2 |
| regulation of cellular process (GO:0050794) | 0.5 | 2 | FGFR1, FGFR2 |
| positive regulation of MAPK cascade (GO:0043410) | 3.57 | 2 | FGFR1, FGFR2 |
| macromolecule modification (GO:0043412) | 1.73 | 2 | FGFR1, FGFR2 |
| protein modification process (GO:0036211) | 1.79 | 2 | FGFR1, FGFR2 |
| regulation of multicellular organismal process (GO:0051239) | 1.87 | 2 | FGFR1, FGFR2 |
| positive regulation of intracellular signal transduction (GO:1902533) | 2.95 | 2 | FGFR1, FGFR2 |
| regulation of ossification (GO:0030278) | 4.53 | 2 | FGFR1, FGFR2 |
| regulation of cardiac muscle tissue growth (GO:0055021) | 6.12 | 2 | FGFR1, FGFR2 |
| organophosphate biosynthetic process (GO:0090407) | 3.67 | 2 | FGFR1, FGFR2 |
| inositol lipid-mediated signaling (GO:0048017) | 4.91 | 2 | FGFR1, FGFR2 |
| positive regulation of macromolecule metabolic process (GO:0010604) | 1.81 | 2 | FGFR1, FGFR2 |
| regulation of hydrolase activity (GO:0051336) | 2.53 | 2 | FGFR1, FGFR2 |
| regulation of phosphorus metabolic process (GO:0051174) | 2.35 | 2 | FGFR1, FGFR2 |
| phospholipid biosynthetic process (GO:0008654) | 4.39 | 2 | FGFR1, FGFR2 |
| positive regulation of protein modification process (GO:0031401) | 2.7 | 2 | FGFR1, FGFR2 |
| positive regulation of mesenchymal cell proliferation (GO:0002053) | 6.4 | 2 | FGFR1, FGFR2 |
| regulation of transcription, DNA-templated (GO:0006355) | 1.56 | 2 | FGFR1, FGFR2 |
| regulation of macromolecule biosynthetic process (GO:0010556) | 1.43 | 2 | FGFR1, FGFR2 |
| positive regulation of signal transduction (GO:0009967) | 2.5 | 2 | FGFR1, FGFR2 |
| negative regulation of macromolecule biosynthetic process (GO:0010558) | 2.53 | 2 | FGFR1, FGFR2 |
| positive regulation of developmental growth (GO:0048639) | 4.67 | 2 | FGFR1, FGFR2 |
| regulation of developmental growth (GO:0048638) | 4.04 | 2 | FGFR1, FGFR2 |
| regulation of lipase activity (GO:0060191) | 5.31 | 2 | FGFR1, FGFR2 |
| positive regulation of catalytic activity (GO:0043085) | 2.4 | 2 | FGFR1, FGFR2 |
| phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 5.84 | 2 | FGFR1, FGFR2 |
| positive regulation of multicellular organismal process (GO:0051240) | 2.49 | 2 | FGFR1, FGFR2 |
| peptidyl-tyrosine modification (GO:0018212) | 4.47 | 2 | FGFR1, FGFR2 |
| cell differentiation (GO:0030154) | 2.14 | 2 | FGFR1, FGFR2 |
| regulation of muscle organ development (GO:0048634) | 5.07 | 2 | FGFR1, FGFR2 |
| neuronal stem cell division (GO:0036445) | 7.53 | 2 | FGFR1, FGFR2 |
| positive regulation of muscle organ development (GO:0048636) | 5.69 | 2 | FGFR1, FGFR2 |
| positive regulation of signaling (GO:0023056) | 2.41 | 2 | FGFR1, FGFR2 |
| embryo development (GO:0009790) | 4.2 | 2 | FGFR1, FGFR2 |
| embryo development ending in birth or egg hatching (GO:0009792) | 4.35 | 2 | FGFR1, FGFR2 |
| signaling (GO:0023052) | 3.25 | 2 | FGFR1, FGFR2 |
| negative regulation of biological process (GO:0048519) | 1.33 | 2 | FGFR1, FGFR2 |
| regulation of intracellular signal transduction (GO:1902531) | 2.31 | 2 | FGFR1, FGFR2 |
| regulation of cardiac muscle cell proliferation (GO:0060043) | 6.33 | 2 | FGFR1, FGFR2 |
| positive regulation of cell communication (GO:0010647) | 2.41 | 2 | FGFR1, FGFR2 |
| anatomical structure morphogenesis (GO:0009653) | 2.53 | 2 | FGFR1, FGFR2 |
| fibroblast growth factor receptor signaling pathway (GO:0008543) | 5.3 | 2 | FGFR1, FGFR2 |
| protein autophosphorylation (GO:0046777) | 4.46 | 2 | FGFR1, FGFR2 |
| single-organism process (GO:0044699) | 0.48 | 2 | FGFR1, FGFR2 |
| orbitofrontal cortex development (GO:0021769) | 8.34 | 2 | FGFR1, FGFR2 |
| regulation of cellular response to growth factor stimulus (GO:0090287) | 4.29 | 2 | FGFR1, FGFR2 |
| in utero embryonic development (GO:0001701) | 4.4 | 2 | FGFR1, FGFR2 |
| negative regulation of transcription from RNA polymerase II promoter (GO:0000122) | 3.12 | 2 | FGFR1, FGFR2 |
| phosphatidylinositol-mediated signaling (GO:0048015) | 4.93 | 2 | FGFR1, FGFR2 |
| positive regulation of phosphorus metabolic process (GO:0010562) | 2.78 | 2 | FGFR1, FGFR2 |
| regulation of protein metabolic process (GO:0051246) | 1.93 | 2 | FGFR1, FGFR2 |
| positive regulation of protein metabolic process (GO:0051247) | 2.43 | 2 | FGFR1, FGFR2 |
| lipid phosphorylation (GO:0046834) | 5.13 | 2 | FGFR1, FGFR2 |
| positive regulation of cellular protein metabolic process (GO:0032270) | 2.49 | 2 | FGFR1, FGFR2 |
| branching involved in salivary gland morphogenesis (GO:0060445) | 7.33 | 2 | FGFR1, FGFR2 |
| regulation of morphogenesis of a branching structure (GO:0060688) | 5.76 | 2 | FGFR1, FGFR2 |
| regulation of protein modification process (GO:0031399) | 2.32 | 2 | FGFR1, FGFR2 |
| central nervous system neuron development (GO:0021954) | 6.26 | 2 | FGFR1, FGFR2 |
| chordate embryonic development (GO:0043009) | 4.38 | 2 | FGFR1, FGFR2 |
| positive regulation of cell proliferation (GO:0008284) | 3.01 | 2 | FGFR1, FGFR2 |
| phospholipid metabolic process (GO:0006644) | 3.88 | 2 | FGFR1, FGFR2 |
| fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development (GO:0035607) | 9.04 | 2 | FGFR1, FGFR2 |
| regulation of cellular metabolic process (GO:0031323) | 1.07 | 2 | FGFR1, FGFR2 |
| cellular process (GO:0009987) | 0.26 | 2 | FGFR1, FGFR2 |
| regulation of nucleic acid-templated transcription (GO:1903506) | 1.55 | 2 | FGFR1, FGFR2 |
| negative regulation of nucleic acid-templated transcription (GO:1903507) | 2.71 | 2 | FGFR1, FGFR2 |
| regulation of cell differentiation (GO:0045595) | 2.42 | 2 | FGFR1, FGFR2 |
| mesonephric epithelium development (GO:0072163) | 5.8 | 2 | FGFR1, FGFR2 |
| mesonephric tubule development (GO:0072164) | 5.82 | 2 | FGFR1, FGFR2 |
| ureteric bud development (GO:0001657) | 5.97 | 2 | FGFR1, FGFR2 |
| positive regulation of heart growth (GO:0060421) | 6.43 | 2 | FGFR1, FGFR2 |
| cellular lipid metabolic process (GO:0044255) | 2.92 | 2 | FGFR1, FGFR2 |
| regulation of phosphatidylinositol 3-kinase signaling (GO:0014066) | 4.79 | 2 | FGFR1, FGFR2 |
| lipid modification (GO:0030258) | 4.37 | 2 | FGFR1, FGFR2 |
| regulation of cellular protein metabolic process (GO:0032268) | 1.99 | 2 | FGFR1, FGFR2 |
| positive regulation of developmental process (GO:0051094) | 2.77 | 2 | FGFR1, FGFR2 |
| negative regulation of RNA metabolic process (GO:0051253) | 2.66 | 2 | FGFR1, FGFR2 |
| regulation of RNA metabolic process (GO:0051252) | 1.52 | 2 | FGFR1, FGFR2 |
| macromolecule metabolic process (GO:0043170) | 0.83 | 2 | FGFR1, FGFR2 |
| organic substance biosynthetic process (GO:1901576) | 1.34 | 2 | FGFR1, FGFR2 |
| glycerophospholipid biosynthetic process (GO:0046474) | 4.62 | 2 | FGFR1, FGFR2 |
| stem cell division (GO:0017145) | 6.47 | 2 | FGFR1, FGFR2 |
| developmental process (GO:0032502) | 1.36 | 2 | FGFR1, FGFR2 |
| regulation of cell fate commitment (GO:0010453) | 6.47 | 2 | FGFR1, FGFR2 |
| lung development (GO:0030324) | 5.13 | 2 | FGFR1, FGFR2 |
| positive regulation of growth (GO:0045927) | 4.25 | 2 | FGFR1, FGFR2 |
| mesenchymal cell differentiation (GO:0048762) | 6.51 | 2 | FGFR1, FGFR2 |
| cell projection organization (GO:0030030) | 3.14 | 2 | FGFR1, FGFR2 |
| regulation of cellular biosynthetic process (GO:0031326) | 1.38 | 2 | FGFR1, FGFR2 |
| positive regulation of cellular metabolic process (GO:0031325) | 1.81 | 2 | FGFR1, FGFR2 |
| negative regulation of cellular metabolic process (GO:0031324) | 2.01 | 2 | FGFR1, FGFR2 |
| gland morphogenesis (GO:0022612) | 6.36 | 2 | FGFR1, FGFR2 |
| regulation of heart growth (GO:0060420) | 5.97 | 2 | FGFR1, FGFR2 |
| peptidyl-tyrosine phosphorylation (GO:0018108) | 4.48 | 2 | FGFR1, FGFR2 |
| multicellular organismal process (GO:0032501) | 1.45 | 2 | FGFR1, FGFR2 |
| angiogenesis (GO:0001525) | 4.15 | 2 | FGFR1, FGFR2 |
| multicellular organism development (GO:0007275) | 2.54 | 2 | FGFR1, FGFR2 |
| cell division (GO:0051301) | 3.68 | 2 | FGFR1, FGFR2 |
| glycerolipid biosynthetic process (GO:0045017) | 4.53 | 2 | FGFR1, FGFR2 |
| regulation of growth (GO:0040008) | 3.26 | 2 | FGFR1, FGFR2 |
| regulation of cellular macromolecule biosynthetic process (GO:2000112) | 1.46 | 2 | FGFR1, FGFR2 |
| negative regulation of cellular macromolecule biosynthetic process (GO:2000113) | 2.6 | 2 | FGFR1, FGFR2 |
| kidney epithelium development (GO:0072073) | 5.54 | 2 | FGFR1, FGFR2 |
| organic substance metabolic process (GO:0071704) | 0.63 | 2 | FGFR1, FGFR2 |
| negative regulation of cellular biosynthetic process (GO:0031327) | 2.49 | 2 | FGFR1, FGFR2 |
| regulation of transcription from RNA polymerase II promoter (GO:0006357) | 2.24 | 2 | FGFR1, FGFR2 |
| tissue morphogenesis (GO:0048729) | 3.87 | 2 | FGFR1, FGFR2 |
| regulation of multicellular organismal development (GO:2000026) | 2.31 | 2 | FGFR1, FGFR2 |
| regulation of gene expression (GO:0010468) | 1.37 | 2 | FGFR1, FGFR2 |
| midbrain development (GO:0030901) | 6.17 | 2 | FGFR1, FGFR2 |
| embryonic morphogenesis (GO:0048598) | 3.72 | 2 | FGFR1, FGFR2 |
| protein phosphorylation (GO:0006468) | 2.89 | 2 | FGFR1, FGFR2 |
| epithelium development (GO:0060429) | 4.57 | 2 | FGFR1, FGFR2 |
| neuron development (GO:0048666) | 4.8 | 2 | FGFR1, FGFR2 |
| negative regulation of nucleobase-containing compound metabolic process (GO:0045934) | 2.55 | 2 | FGFR1, FGFR2 |
| positive regulation of phosphate metabolic process (GO:0045937) | 2.78 | 2 | FGFR1, FGFR2 |
| morphogenesis of a branching epithelium (GO:0061138) | 4.77 | 2 | FGFR1, FGFR2 |
| regulation of nucleobase-containing compound metabolic process (GO:0019219) | 1.43 | 2 | FGFR1, FGFR2 |
| cell-cell signaling (GO:0007267) | 3.35 | 2 | FGFR1, FGFR2 |
| positive regulation of organ growth (GO:0046622) | 6.09 | 2 | FGFR1, FGFR2 |
| cellular protein modification process (GO:0006464) | 1.79 | 2 | FGFR1, FGFR2 |
| single-organism developmental process (GO:0044767) | 1.49 | 2 | FGFR1, FGFR2 |
| biosynthetic process (GO:0009058) | 1.32 | 2 | FGFR1, FGFR2 |
| single-organism cellular process (GO:0044763) | 0.65 | 2 | FGFR1, FGFR2 |
| regulation of nitrogen compound metabolic process (GO:0051171) | 1.36 | 2 | FGFR1, FGFR2 |
| negative regulation of nitrogen compound metabolic process (GO:0051172) | 2.47 | 2 | FGFR1, FGFR2 |
| lung-associated mesenchyme development (GO:0060484) | 7.43 | 2 | FGFR1, FGFR2 |
| mesenchyme development (GO:0060485) | 5.7 | 2 | FGFR1, FGFR2 |
| tube development (GO:0035295) | 4.41 | 2 | FGFR1, FGFR2 |
| lipid biosynthetic process (GO:0008610) | 3.49 | 2 | FGFR1, FGFR2 |
| primary metabolic process (GO:0044238) | 0.69 | 2 | FGFR1, FGFR2 |
| inner ear morphogenesis (GO:0042472) | 5.62 | 2 | FGFR1, FGFR2 |
| cellular macromolecule metabolic process (GO:0044260) | 0.93 | 2 | FGFR1, FGFR2 |
| regulation of cell cycle (GO:0051726) | 2.93 | 2 | FGFR1, FGFR2 |
| anatomical structure development (GO:0048856) | 1.58 | 2 | FGFR1, FGFR2 |
| cellular metabolic process (GO:0044237) | 0.69 | 2 | FGFR1, FGFR2 |
| positive regulation of phospholipase activity (GO:0010518) | 5.76 | 2 | FGFR1, FGFR2 |
| phosphate-containing compound metabolic process (GO:0006796) | 2.16 | 2 | FGFR1, FGFR2 |
| forebrain ventricular zone progenitor cell division (GO:0021869) | 7.94 | 2 | FGFR1, FGFR2 |
| regulation of organ morphogenesis (GO:2000027) | 4.22 | 2 | FGFR1, FGFR2 |
| phosphorus metabolic process (GO:0006793) | 2.15 | 2 | FGFR1, FGFR2 |
| negative regulation of transcription, DNA-templated (GO:0045892) | 2.75 | 2 | FGFR1, FGFR2 |
| regulation of protein phosphorylation (GO:0001932) | 2.57 | 2 | FGFR1, FGFR2 |
| cellular biosynthetic process (GO:0044249) | 1.37 | 2 | FGFR1, FGFR2 |
| positive regulation of protein phosphorylation (GO:0001934) | 2.95 | 2 | FGFR1, FGFR2 |
| negative regulation of cellular process (GO:0048523) | 1.41 | 2 | FGFR1, FGFR2 |
| positive regulation of cellular process (GO:0048522) | 1.3 | 2 | FGFR1, FGFR2 |